ECSP045381A - Polipéptidos y rutas biosintéticas - Google Patents

Polipéptidos y rutas biosintéticas

Info

Publication number
ECSP045381A
ECSP045381A EC2004005381A ECSP045381A ECSP045381A EC SP045381 A ECSP045381 A EC SP045381A EC 2004005381 A EC2004005381 A EC 2004005381A EC SP045381 A ECSP045381 A EC SP045381A EC SP045381 A ECSP045381 A EC SP045381A
Authority
EC
Ecuador
Prior art keywords
indole
methods
pyruvate
hydroxy
routes
Prior art date
Application number
EC2004005381A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=29270554&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ECSP045381(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of ECSP045381A publication Critical patent/ECSP045381A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0006—Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0012—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
    • C12N9/0014—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on the CH-NH2 group of donors (1.4)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0012—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
    • C12N9/0014—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on the CH-NH2 group of donors (1.4)
    • C12N9/0016—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on the CH-NH2 group of donors (1.4) with NAD or NADP as acceptor (1.4.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1096—Transferases (2.) transferring nitrogenous groups (2.6)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/10—Nitrogen as only ring hetero atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Indole Compounds (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Un método para producir monatin comprometiendo la conversión de glucosa a monatin.
EC2004005381A 2002-04-23 2004-10-22 Polipéptidos y rutas biosintéticas ECSP045381A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US37483102P 2002-04-23 2002-04-23

Publications (1)

Publication Number Publication Date
ECSP045381A true ECSP045381A (es) 2005-01-03

Family

ID=29270554

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2004005381A ECSP045381A (es) 2002-04-23 2004-10-22 Polipéptidos y rutas biosintéticas

Country Status (24)

Country Link
US (1) US20040063175A1 (es)
EP (2) EP1503985B1 (es)
JP (3) JP2005523696A (es)
KR (1) KR100902813B1 (es)
CN (1) CN100516043C (es)
AT (1) ATE491803T1 (es)
AU (2) AU2003263097A1 (es)
BR (1) BRPI0309527B1 (es)
CA (1) CA2483126C (es)
CO (1) CO5631430A2 (es)
DE (1) DE60335361D1 (es)
EA (1) EA009284B1 (es)
EC (1) ECSP045381A (es)
ES (1) ES2356132T3 (es)
GE (1) GEP20084387B (es)
IL (1) IL164548A0 (es)
MX (1) MXPA04010522A (es)
NO (1) NO20045029L (es)
NZ (2) NZ555884A (es)
PL (2) PL208481B1 (es)
RS (1) RS92604A (es)
SG (1) SG146453A1 (es)
WO (1) WO2003091396A2 (es)
ZA (1) ZA200408379B (es)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7297800B2 (en) * 2001-12-27 2007-11-20 Ajinomoto Co., Inc. Process of producing glutamate derivatives
CN100465156C (zh) 2001-12-27 2009-03-04 味之素株式会社 谷氨酸化合物及其制备中间体的制造方法与为此所用的新型中间体
KR100775778B1 (ko) * 2001-12-27 2007-11-12 아지노모토 가부시키가이샤 글루탐산 유도체의 제조방법
US8372989B2 (en) 2002-04-23 2013-02-12 Cargill, Incorporated Polypeptides and biosynthetic pathways for the production of monatin and its precursors
US7572607B2 (en) * 2002-04-23 2009-08-11 Cargill, Incorporated Polypeptides and biosynthetic pathways for the production of monatin and its precursors
CA2484871C (en) 2002-08-26 2010-11-30 Ajinomoto Co., Inc. Novel aldolase and production process of substituted .alpha.-keto acids
JP2006512086A (ja) * 2002-09-20 2006-04-13 ダイヴァーサ コーポレイション スタチンおよびスタチン中間体の合成のための酵素化学的方法
EP2557160A3 (en) 2002-12-09 2013-03-27 Ajinomoto Co., Inc. Mutated D-aminotransferase and method for producing optically active glutamic acid derivatives using the same
JP4760375B2 (ja) * 2003-06-26 2011-08-31 味の素株式会社 Ｉｈｏｇの回収方法およびモナティンの製造方法
US20050112260A1 (en) * 2003-08-01 2005-05-26 Cargill, Inc. Monatin tabletop sweetener compositions and methods of making same
CN1852661B (zh) * 2003-08-14 2010-08-18 嘉吉有限公司 含有莫那甜的口香糖组合物及其制造方法
CN1849078B (zh) * 2003-08-25 2011-04-20 嘉吉有限公司 含有莫纳甜的饮料组合物及其制造方法
EP1678313B1 (en) * 2003-10-21 2011-02-16 Cargill, Incorporated Production of monatin and monatin precursors
JP4797452B2 (ja) * 2004-06-07 2011-10-19 味の素株式会社 新規アルドラーゼ並びに光学活性ｉｈｏｇ及びモナティンの製造方法
CA2506247C (en) 2004-06-07 2012-02-21 Ajinomoto Co., Inc. Novel aldolase, and method for producing optically active ihog and monatin
US7180370B2 (en) * 2004-09-01 2007-02-20 Micron Technology, Inc. CMOS amplifiers with frequency compensating capacitors
US8158389B2 (en) 2005-04-20 2012-04-17 Cargill, Incorporated Products and methods for in vivo secretion of monatin
JP5059746B2 (ja) * 2005-04-20 2012-10-31 カーギル，インコーポレイティド モナチンの生体内分泌のための生成物及び方法
US8076108B2 (en) * 2005-04-26 2011-12-13 Cargill, Incorporated Polypeptides and biosynthetic pathways for the production of stereoisomers of monatin and their precursors
US7582455B2 (en) * 2005-04-26 2009-09-01 Cargill, Incorporated Polypeptides and biosynthetic pathways for the production of stereoisomers of monatin and their precursors
EP2361976B1 (en) 2005-04-26 2016-05-25 Cargill, Incorporated Polypeptides and biosynthetic pathways for the production of stereoisomers of monatin and their precursors
US8043837B2 (en) 2006-03-07 2011-10-25 Cargill, Incorporated Aldolases, nucleic acids encoding them and methods for making and using them
ATE548450T1 (de) 2006-03-07 2012-03-15 Verenium Corp Aldolasen, nukleinsäuren zu ihrer kodierung sowie verfahren zu ihrer herstellung und verwendung
JP2009538145A (ja) 2006-05-24 2009-11-05 カーギル・インコーポレイテッド 平衡反応の収量を増加させるための方法およびシステム
US20090198072A1 (en) * 2006-05-24 2009-08-06 Cargill, Incorporated Methods and systems for increasing production of equilibrium reactions
CN101239941B (zh) * 2007-02-08 2012-02-29 味之素株式会社 光学活性化合物的制造方法
WO2009028338A1 (ja) 2007-08-24 2009-03-05 Ajinomoto Co., Inc. 新規オキシダーゼ遺伝子、および該遺伝子を利用する３－インドールピルビン酸の製造方法
US8076107B2 (en) * 2007-10-01 2011-12-13 Cargill, Incorporated Production of monatin stereoisomers
US8367847B2 (en) * 2007-10-01 2013-02-05 Cargill, Incorporated Production of monatin enantiomers
US8003361B2 (en) * 2007-10-01 2011-08-23 Cargill Incorporated Production of monatin enantiomers
US8709772B2 (en) 2008-01-03 2014-04-29 Verenium Corporation Transferases and oxidoreductases, nucleic acids encoding them and methods for making and using them
AU2008347048B2 (en) * 2008-01-03 2014-06-05 Cargill, Incorporated Aminotransferase and oxidoreductase nucleic acids and polypeptides and methods of using
CA2763128A1 (en) 2009-05-28 2010-12-02 Cargill, Incorporated Shelf stable monatin sweetened beverage
WO2011082351A1 (en) 2009-12-30 2011-07-07 Cargill, Incorporated A polymer and methods of preparing and using a polymer
US8445226B2 (en) * 2010-02-01 2013-05-21 Microbios, Inc. Process and composition for the manufacture of a microbial-based product
US9023627B2 (en) 2010-09-15 2015-05-05 University Of Washington Through Its Center For Commercialization Systems and methods for biotransformation of carbon dioxide into higher carbon compounds
EP2479272A4 (en) 2010-10-14 2013-11-20 Ajinomoto Kk PROCESS FOR THE PRODUCTION OF MONATIN
WO2012135389A2 (en) 2011-03-28 2012-10-04 The Regents Of The University Of California Host cells and methods for oxidizing aromatic amino acids
WO2012147674A1 (ja) * 2011-04-25 2012-11-01 味の素株式会社 モナティンの製造方法
GB201412545D0 (en) * 2014-07-15 2014-08-27 Univ Manchester The And Manchester Metropolitan University Enzymatic processes and uses
CN112931181A (zh) * 2021-01-28 2021-06-11 西北农林科技大学 一种抗根肿病橙色大白菜新种质的选育方法

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3002889A (en) * 1960-06-20 1961-10-03 Kyowa Hakko Kogyo Kk Method of producing l-glutamic acid
US3128237A (en) * 1961-02-24 1964-04-07 Ajinomoto Kk Process for producing l-glutamic acid by bacterial fermentation
US4371614A (en) * 1980-08-22 1983-02-01 Ajinomoto Co., Inc. E.Coli bacteria carrying recombinant plasmids and their use in the fermentative production of L-tryptophan
IL67510A (en) * 1981-12-17 1988-08-31 Kyowa Hakko Kogyo Kk Recombinant vector plasmids autonomously replicable in microorganisms belonging to the genus corynebacterium or brevibacterium and process for the production thereof
JPS60176593A (ja) 1984-02-22 1985-09-10 Kyowa Hakko Kogyo Co Ltd Ｌ−トリプトフアンの製造法
US5264550A (en) 1985-04-15 1993-11-23 Scios Nova Inc. Human anti-inflammatory phospholipase inhibitor protein
WO1987001130A1 (en) 1985-08-15 1987-02-26 Stauffer Chemical Company Tryptophan producing microorganism
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US5260203A (en) 1986-09-02 1993-11-09 Enzon, Inc. Single polypeptide chain binding molecules
GB2205834B (en) * 1987-06-15 1990-10-31 South African Inventions 3-(1-amino-1,3-dicarboxy-3-hydroxy-but-4-yl)-indole compounds
US5300437A (en) * 1989-06-22 1994-04-05 Celgene Corporation Enantiomeric enrichment and stereoselective synthesis of chiral amines
ES2063443T3 (es) * 1990-01-19 1995-01-01 Technology Finance Corp Procedimiento para la produccion de 3-(1-amino-1,3-dicarboxi-3-hidroxi-but-4-il) indol.
US5173497A (en) 1990-05-17 1992-12-22 Hoechst-Roussel Pharmaceuticals Incorporated Alpha-oxopyrrolo[2,3-B]indole acetic acids, esters, amides and related analogs
WO1993006217A1 (en) 1991-09-19 1993-04-01 Genentech, Inc. EXPRESSION IN E. COLI OF ANTIBODY FRAGMENTS HAVING AT LEAST A CYSTEINE PRESENT AS A FREE THIOL, USE FOR THE PRODUCTION OF BIFUNCTIONAL F(ab')2 ANTIBODIES
FR2686899B1 (fr) * 1992-01-31 1995-09-01 Rhone Poulenc Rorer Sa Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
US5360724A (en) * 1992-12-18 1994-11-01 Celgene Corporation Process for the preparation of chiral 1-aryl-2-aminopropanes
US5691188A (en) 1994-02-14 1997-11-25 American Cyanamid Company Transformed yeast cells expressing heterologous G-protein coupled receptor
JP3698742B2 (ja) 1994-03-01 2005-09-21 協和醗酵工業株式会社 光学活性４−ヒドロキシ−２−ケトグルタル酸の製造法
EP0872547B1 (en) * 1994-08-30 2007-12-26 Ajinomoto Co., Inc. Process for producing l-valine and l-leucine
US5985617A (en) * 1997-02-18 1999-11-16 Liao; James C. Microorganisms and methods for overproduction of DAHP by cloned PPS gene
DE69534848T2 (de) * 1994-09-16 2006-11-23 The Texas A & M University System, College Station Mikroorganismen und Verfahren zur Überproduktion von DAHP mittels klonierten PPSGens
US5843782A (en) * 1995-02-09 1998-12-01 Novaflora, Inc. Micropropagation of rose plants
GB2304718B (en) * 1995-09-05 2000-01-19 Degussa The production of tryptophan by the bacterium escherichia coli
CA2234412C (en) * 1997-06-09 2008-09-02 Kyowa Hakko Kogyo Co., Ltd. Method for producing optically active compound
US5994559A (en) * 1998-08-06 1999-11-30 The Board Of Governors For Higher Education, State Of Rhode Island And Providence Plantations Synthesis of monatin-A high intensity natural sweetener
CA2944644C (en) 1999-05-07 2017-08-22 Genentech, Inc. Use of rituximab to treat pemphigus
US6428504B1 (en) * 2000-04-06 2002-08-06 Varian Medical Systems, Inc. Multipurpose template and needles for the delivery and monitoring of multiple minimally invasive therapies
JP2002060382A (ja) * 2000-08-22 2002-02-26 Ajinomoto Co Inc モナティンの立体異性体及びその使用、並びにモナティン類の製造方法及びそのための中間体
JP3713224B2 (ja) * 2001-08-10 2005-11-09 株式会社三栄水栓製作所 水栓取替方法
KR100775778B1 (ko) * 2001-12-27 2007-11-12 아지노모토 가부시키가이샤 글루탐산 유도체의 제조방법

Also Published As

Publication number Publication date
NZ555884A (en) 2008-10-31
PL208481B1 (pl) 2011-05-31
AU2010201699B2 (en) 2013-02-07
US20040063175A1 (en) 2004-04-01
KR100902813B1 (ko) 2009-06-12
BR0309527A (pt) 2005-06-28
ZA200408379B (en) 2006-05-31
EP2354240A1 (en) 2011-08-10
MXPA04010522A (es) 2004-12-13
DE60335361D1 (de) 2011-01-27
EP1503985A4 (en) 2006-11-02
JP4988803B2 (ja) 2012-08-01
JP2011250806A (ja) 2011-12-15
EP1503985A2 (en) 2005-02-09
NO20045029L (no) 2005-01-04
CO5631430A2 (es) 2006-04-28
EA009284B1 (ru) 2007-12-28
EP2354240B1 (en) 2016-07-06
RS92604A (en) 2007-09-21
PL373423A1 (en) 2005-08-22
IL164548A0 (en) 2005-12-18
BRPI0309527B1 (pt) 2015-08-18
ES2356132T3 (es) 2011-04-05
AU2010201699A1 (en) 2010-05-20
CA2483126C (en) 2014-05-20
SG146453A1 (en) 2008-10-30
JP2005523696A (ja) 2005-08-11
JP5351230B2 (ja) 2013-11-27
WO2003091396A3 (en) 2004-03-11
EA200401228A1 (ru) 2006-04-28
CA2483126A1 (en) 2003-11-06
ATE491803T1 (de) 2011-01-15
PL208998B1 (pl) 2011-07-29
WO2003091396A2 (en) 2003-11-06
CN100516043C (zh) 2009-07-22
EP1503985B1 (en) 2010-12-15
AU2003263097A1 (en) 2003-11-10
JP2010004896A (ja) 2010-01-14
NZ535297A (en) 2008-05-30
KR20080056274A (ko) 2008-06-20
CN1656068A (zh) 2005-08-17
GEP20084387B (en) 2008-06-10

Similar Documents

Publication Publication Date Title
CO5631430A2 (es) Polipeptidos y rutas biosinteticas
BRPI0415763A (pt) produção de monatina e precursores de monatina
MA28337A1 (fr) Derives de l'acide 7-phenylamino-4-quinolone-3-carboxylique, methodes pour leur production et leur utilisation en tant que medicaments
DK1224170T3 (da) I 6-position substitueret indolin, fremstilling og anvendelse deraf som lægemiddel
NO20082240L (no) GLP-2 imitatorstoff, polypeptider, sammensetninger, fremgangsmater og anvendelser
ATE543873T1 (de) Herstellung von 3-hydroxypropionsäure mittels beta-alanine-pyruvat-aminotrransferase
HK1162587A1 (en) Non-tumorigenic mdck cell line for propagating viruses mdck
DE602005003648D1 (de) Derivate von alkylpiperazin- und alkylhomopiperazincarboxylaten, verfahren zu deren herstellung und deren verwendung als inhibitoren des faah-enzyms
ATE406361T1 (de) 3-substituierte 5,6-diaryl-pyrazin-2- carbonsäureamid- und -2-sulfonsäureamidderivative als cb1 modulatoren
ATE417827T1 (de) Fluvastatin-natrium in der kristallform xiv, verfahren zu deren herstellung, diese enthaltende zusammensetzungen und enstprechende anwendungsverfahren
WO2003093469A3 (en) Methods for delivering nucleic acid molecules into cells and assessment thereof
IL188998A0 (en) Supported gold catalyst and methods for the production thereof
DE60100620D1 (de) Gezielte elektrochemische reduktion von halogenierten 4-amino-picolinsäuren
PL1846412T3 (pl) Sposób wytwarzania 7-etylo-10-hydroksykamptotecyny
ATE344055T1 (de) Zusammensetzungen für die elektroporation
IS7154A (is) Bv8 kjarnsýrur og fjölpeptíð með mítósu-valdandi verkun
EP3467112A3 (en) Methods for transfecting nucleic acids into live cells
ATE388936T1 (de) 9-chloro-15-deoxyprostaglandinderivate, verfahren zu ihrer herstellung und deren verwendung als medikamente
WO2006081463A3 (en) Thermococcus zilligii dna polymerases and variants thereof
DK1348684T3 (da) Fremgangsmåde til syntese af (2S)-indolin-2-carboxylsyre og anvendelse heraf til syntese af perindopril
DE60323748D1 (de) 1,3-diaza-dibenzoazulene als inhibitoren der produfür deren herstellung
CU20040242A7 (es) Polipéptidos y pasos biosintéticos
DK1354876T3 (da) Fremgangsmåde til syntese af (2S,3aS,7aS)-perhydroindol-2-carboxylsyre og dennes estere og anvendelse heraf i syntesen af perindopril
DE602005014475D1 (de) Nukleinsäure/enzym-komplex
ATE405550T1 (de) Polysubstituierte 1,1- pyridinyloxycyclopropanamine derivate, verfahren zu ihrer herstellung und die enthaltenden pharmazeutischen zusammensetzungen